Resistin induces insulin resistance in pancreatic islets to impair glucose-induced insulin release

Biochemical and Biophysical Research Communications

Volumn 353, Issue 4, 2007, Pages 1046-1051

  Nakata, Masanori ^a   Okada, Takashi ^a   Ozawa, Keiya ^a   Yada, Toshihiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Adipokine; Insulin; Obesity; Pancreatic cell; Resistin

Indexed keywords

ADENOVIRUS VECTOR; ADIPOCYTOKINE; CYSTEINE; GLUCOSE; INSULIN; PROTEIN KINASE B; RESISTIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GLUCOSE TOLERANCE; IN VITRO STUDY; INSULIN RELEASE; INSULIN RESISTANCE; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION;

ADENOVIRIDAE; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; CELL LINE; GENETIC VECTORS; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED ICR; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RESISTIN; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

ADENOVIRIDAE; MUS;

EID: 33846134010     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.134     Document Type: Article

References (25)

1. Reaven G.M. Role of insulin resistance in human. Diabetes 37 (1988) 1595-1607
2. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., and Lazar M.A. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
3. Satoh H., Nguyen M.T., Miles P.D., Imamura T., Usui I., and Olefsky J.M. Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J. Clin. Invest. 114 (2004) 224-231
4. Muse E.D., Obici S., Bhanot S., Monia B.P., McKay R.A., Rajala M.W., Scherer P.E., and Rossetti L. Role of resistin in diet-induced hepatic insulin resistance. J. Clin. Invest. 114 (2004) 232-239
5. Pravenec M., Kazdova L., Landa V., Zidek V., Mlejnek P., Jansa P., Wang J., Qi N., and Kurtz T.W. Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J. Biol. Chem. 278 (2003) 45209-45215
6. Rajala M.W., Obici S., Scherer P.E., and Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J. Clin. Invest. 111 (2003) 225-230
7. i increase via JAK2 and tyrosine kinases in a megakaryoblast cell line. Diabetes Res. Clin. Pract. 70 (2005) 209-216
8. Banerjee R.R., Rangwala S.M., Shapiro J.S., Rich A.S., Rhoades B., Qi Y., Wang J., Rajala M.W., Pocai A., Scherer P.E., Steppan C.M., Ahima R.S., Obici S., Rossetti L., and Lazar M.A. Regulation of fasted blood glucose by resistin. Science 303 (2004) 1195-1198
9. Rangwala S.M., Rich A.S., Rhoades B., Shapiro J.S., Obici S., Rossetti L., and Lazar M.A. Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes. 53 (2004) 1937-1941
10. Steppan C.M., Wang J., Whiteman E.L., Birnbaum M.J., and Lazar M.A. Activation of SOCS-3 by resistin. Mol. Cell Biol. 25 (2005) 1569-1575
11. Kitagawa Y., Bujo H., Takahashi K., Shibasaki M., Ishikawa K., Yagui K., Hashimoto N., Noda K., Nakamura T., Yano S., and Saito Y. Impaired glucose tolerance is accompanied by decreased insulin sensitivity in tissues of mice implanted with cells that overexpress resistin. Diabetologia 47 (2004) 1847-1853
12. Kulkarni R.N., Bruning J.C., Winnay J.N., Postic C., Magnuson M.A., and Kahn C.R. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96 (1999) 329-339
13. Otani K., Kulkarni R.N., Baldwin A.C., Krutzfeldt J., Ueki K., Stoffel M., Kahn C.R., and Polonsky K.S. Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E41-E49
14. Cho Y., Youn B., Chung S., Kim K., Lee H., Yu K., Park H., Shin H., and Park K. Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47 (2004) 559-565
15. Azuma K., Katsukawa F., Oguchi S., Murata M., Yamazaki H., Shimada A., and Saruta T. Correlation between serum resistin level and adiposity in obese individuals. Obes. Res. 11 (2003) 997-1001
16. Lee J., Chan J., Yiannakouris N., Kontogianni M., Estrada E., Seip R., Orlova C., and Mantzoros C. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J. Clin. Endocrinol. Metab. 88 (2003) 4848-4856
17. McTernan P., Fisher F., Valsamakis G., Chetty R., Harte A., McTernan C., Clark P., Smith S., Barnett A., and Kumar S. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J. Clin. Endocrinol. Metab. 88 (2003) 6098-6106
18. Fujinami A., Obayashi H., Ohta K., Ichimura T., Nishimura M., Matsui H., Kawahara Y., Yamazaki M., Ogata M., Hasegawa G., Nakamura N., Yoshikawa T., Nakano K., and Ohta M. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin. Chim. Acta 339 (2004) 57-63
19. Youn B.S., Yu K.Y., Park H.J., Lee N.S., Min S.S., Youn M.Y., Cho Y.M., Park Y.J., Kim S.Y., Lee H.K., and Park K.S. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 89 (2004) 150-156
20. Kaser S., Kaser A., Sandhofer A., Ebenbichler C.F., Tilg H., and Patsch J.R. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem. Biophys. Res. Commun. 309 (2003) 286-290
21. Patel L., Buckels A.C., Kinghorn I.L., Murdock P.R., Holbrook J.D., Plumpton C., Macphee C.H., and Smith S.A. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem. Biophys. Res. Commun. 300 (2003) 472-476
22. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., and Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003) 1821-1830
23. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003) 1796-1808
24. Silswal N., Singh A.K., Aruna B., Mukhopadhyay S., Ghosh S., and Ehtesham N.Z. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem. Biophys. Res. Commun. 334 (2005) 1092-1101
25. Fu Y., Luo L., Luo N., and Garvey W.T. Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes. Nutr. Metab. (Lond). 3 (2006) 28